Vetoquinol: 2% drop in annual sales
The good level of sales in the second half of 2023, up 4.5% at constant exchange rates, offset a first half disrupted by cyclical factors, notably the impact of the ERP changeover in the second quarter.
We are actively pursuing the implementation of our strategy, and in particular our ambitious program of innovation, registration and launch of key products", comments Matthieu Frechin, CEO of the animal health laboratory.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction